Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SPRITAM® safely and effectively. See full prescribing information for SPRITAM. SPRITAM (levetiracetam) tablets, for oral suspension Initial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
SPRITAM is indicated for the treatment of partial-onset seizures in patients 4 years of age and older weighing more than 20 kg. SPRITAM is indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. SPRITAM is indicated as adjunctive therapy for the treatment of primary generalized tonic‑clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
- generic_name
- levetiracetam
- product_names
- levetiracetam
- ndc
- 43485-101, 43485-101-01, 43485-101-60, 43485-101-03, 43485-102, 43485-102-01, 43485-102-60, 43485-102-03, 43485-103, 43485-103-01, 43485-103-60, 43485-104, 43485-104-01, 43485-104-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en